vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and VALLEY NATIONAL BANCORP (VLY). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $540.4M, roughly 1.8× VALLEY NATIONAL BANCORP). VALLEY NATIONAL BANCORP runs the higher net margin — 30.3% vs 0.7%, a 29.6% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 13.0%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 16.0%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
VALLEY NATIONAL BANCORPVLYEarnings & Financial Report
North Valley Bancorp was a bank holding company headquartered in Redding, California. The company operated 22 branches. The company was acquired by TriCo Bancshares in October 2014, in a merger valued at more than $178 million.
ASTH vs VLY — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $540.4M |
| Net Profit | $6.6M | $163.9M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | — |
| Net Margin | 0.7% | 30.3% |
| Revenue YoY | 42.9% | 13.0% |
| Net Profit YoY | 184.4% | 54.6% |
| EPS (diluted) | $0.12 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $540.4M | ||
| Q4 25 | $950.5M | $464.9M | ||
| Q3 25 | $956.0M | $446.2M | ||
| Q2 25 | $654.8M | $432.4M | ||
| Q1 25 | $620.4M | $420.1M | ||
| Q4 24 | $665.2M | $423.0M | ||
| Q3 24 | $478.7M | $410.5M | ||
| Q2 24 | $486.3M | $401.7M |
| Q1 26 | — | $163.9M | ||
| Q4 25 | $6.6M | $195.4M | ||
| Q3 25 | $373.0K | $163.4M | ||
| Q2 25 | $9.4M | $133.2M | ||
| Q1 25 | $6.7M | $106.1M | ||
| Q4 24 | $-7.8M | $115.7M | ||
| Q3 24 | $16.1M | $97.9M | ||
| Q2 24 | $19.2M | $70.4M |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 47.7% | ||
| Q3 25 | 2.0% | 47.1% | ||
| Q2 25 | 3.1% | 40.0% | ||
| Q1 25 | 3.3% | 33.1% | ||
| Q4 24 | 0.1% | 21.1% | ||
| Q3 24 | 5.9% | 30.9% | ||
| Q2 24 | 6.2% | 23.2% |
| Q1 26 | — | 30.3% | ||
| Q4 25 | 0.7% | 42.0% | ||
| Q3 25 | 0.0% | 36.6% | ||
| Q2 25 | 1.4% | 30.8% | ||
| Q1 25 | 1.1% | 25.2% | ||
| Q4 24 | -1.2% | 27.4% | ||
| Q3 24 | 3.4% | 23.8% | ||
| Q2 24 | 3.9% | 17.5% |
| Q1 26 | — | $0.29 | ||
| Q4 25 | $0.12 | $0.33 | ||
| Q3 25 | $0.01 | $0.28 | ||
| Q2 25 | $0.19 | $0.22 | ||
| Q1 25 | $0.14 | $0.18 | ||
| Q4 24 | $-0.14 | $0.20 | ||
| Q3 24 | $0.33 | $0.18 | ||
| Q2 24 | $0.40 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | $2.6B |
| Stockholders' EquityBook value | $779.3M | $7.9B |
| Total Assets | $2.2B | $64.5B |
| Debt / EquityLower = less leverage | — | 0.33× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — |
| Q1 26 | — | $2.6B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $7.9B | ||
| Q4 25 | $779.3M | $7.8B | ||
| Q3 25 | $775.5M | $7.7B | ||
| Q2 25 | $765.5M | $7.6B | ||
| Q1 25 | $745.4M | $7.5B | ||
| Q4 24 | $712.7M | $7.4B | ||
| Q3 24 | $704.6M | $7.0B | ||
| Q2 24 | $678.9M | $6.7B |
| Q1 26 | — | $64.5B | ||
| Q4 25 | $2.2B | $64.1B | ||
| Q3 25 | $2.2B | $63.0B | ||
| Q2 25 | $1.4B | $62.7B | ||
| Q1 25 | $1.3B | $61.9B | ||
| Q4 24 | $1.4B | $62.5B | ||
| Q3 24 | $1.3B | $62.1B | ||
| Q2 24 | $1.3B | $62.1B |
| Q1 26 | — | 0.33× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | — |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $196.6M | ||
| Q3 25 | $10.0M | $5.2M | ||
| Q2 25 | $90.9M | $159.2M | ||
| Q1 25 | $16.6M | $-17.1M | ||
| Q4 24 | $-10.9M | $392.2M | ||
| Q3 24 | $34.0M | $-157.2M | ||
| Q2 24 | $23.2M | $214.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $187.5M | ||
| Q3 25 | $7.4M | $2.3M | ||
| Q2 25 | $89.5M | $156.0M | ||
| Q1 25 | $13.6M | $-20.2M | ||
| Q4 24 | $-13.5M | $385.8M | ||
| Q3 24 | $31.7M | $-160.5M | ||
| Q2 24 | $20.4M | $211.3M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 40.3% | ||
| Q3 25 | 0.8% | 0.5% | ||
| Q2 25 | 13.7% | 36.1% | ||
| Q1 25 | 2.2% | -4.8% | ||
| Q4 24 | -2.0% | 91.2% | ||
| Q3 24 | 6.6% | -39.1% | ||
| Q2 24 | 4.2% | 52.6% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.0% | ||
| Q3 25 | 0.3% | 0.6% | ||
| Q2 25 | 0.2% | 0.7% | ||
| Q1 25 | 0.5% | 0.7% | ||
| Q4 24 | 0.4% | 1.5% | ||
| Q3 24 | 0.5% | 0.8% | ||
| Q2 24 | 0.6% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 1.01× | ||
| Q3 25 | 26.69× | 0.03× | ||
| Q2 25 | 9.65× | 1.20× | ||
| Q1 25 | 2.48× | -0.16× | ||
| Q4 24 | — | 3.39× | ||
| Q3 24 | 2.11× | -1.61× | ||
| Q2 24 | 1.21× | 3.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
VLY
Segment breakdown not available.
